Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

Hims is expanding beyond telehealth with a push into hormone care, while building out at-home testing and virtual care services. ・Peptides is also seen as the next growth driver, with Bank of America ...

Two class action lawsuits claim Hims & Hers Health did not adequately safeguard sensitive customer data during recent data ...

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...

Hims & Hers—the virtual care platform with about 2.5 million subscribers—will now offer laboratory testing through Quest Diagnostics. Customers will have access to more than 120 biomarker tests across ...

Hims & Hers Health, Inc. HIMS is scheduled to report first-quarter 2026 results on May 11, after the closing bell. In the ...

The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer The company will offer access to Galleri®, an innovative blood test ...

Hims & Hers Health, Inc. (NYSE: HIMS) announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. • HIMS stock is racing ...

Being left off Novo Nordisk’s partner list introduces meaningful short‑term pressure on Hims & Hers Health, Inc.’s outlook, particularly around the weight‑loss segment. The launch of whole‑body lab ...

Hims & Hers (NYSE: HIMS) announced today the launch of an early detection cancer test, bringing more value to its lab business. This is another product launch that isn't about pushing pills or ...

Hims & Hers said it will offer access to Galleri, a blood-based multi-cancer early detection test from GRAIL Inc. that screens for signals associated with more than 50 types of cancer, including ...

The company will offer access to Galleri®, an innovative blood test from GRAIL, Inc. that screens for more than 50 types of cancer. More than one in three people will develop cancer in their lifetime2 ...